Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): SARS-CoV-2 s-protein based vaccine

            Therapeutic Area: Infections and Infectious Diseases Product Name: BVX-0320

            Highest Development Status: Preclinical Product Type: Vaccine

            Partner/Sponsor/Collaborator: Biovaxys

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Agreement March 15, 2021

            Details:

            Under the terms of the agreement, WuXi Bio will synthesize high yields of fully characterized, Good Laboratory Practice (GLP) grade SARS-CoV-2 s-protein required by BioVaxys for BVX-0320, its COVID-19 vaccine candidate, and for its Covid-T™ immunodiagnostic program.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): AS1411

            Therapeutic Area: Infections and Infectious Diseases Product Name: AS1411

            Highest Development Status: Preclinical Product Type: Large molecule

            Partner/Sponsor/Collaborator: Qualigen Therapeutics

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Agreement November 05, 2020

            Details:

            Qualigen Therapeutics has signed a contract with STA Pharmaceutical, a subsidiary of WuXi AppTec, for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.